(Q37126579)

18 August 2017

Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control (English)

1 reference

18 August 2017

0 references

0 references

Concetta Schiano

9

0 references

Michelangela Barbieri

Michelangela Barbieri

7

0 references

Giuseppe Paolisso

Giuseppe Paolisso

12

0 references

Claudio Napoli

Claudio Napoli

13

0 references

Linda Sommese

10

Linda Sommese

1 reference

18 August 2017

Sergio Brongo

6

0 references

Nicola Ferrara

Nicola Ferrara

11

0 references

author name string

Maria Rosaria De Pascale

1

1 reference

18 August 2017

Giuseppe Bruzzese

2

1 reference

18 August 2017

Ettore Crimi

3

1 reference

18 August 2017

Vincenzo Grimaldi

4

1 reference

18 August 2017

Antonio Liguori

5

1 reference

18 August 2017

Antonietta Picascia

8

1 reference

18 August 2017

1 May 2016

1 reference

International journal of stem cells

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

1

1 reference

18 August 2017

137-144

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

18 August 2017

start time

31 May 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Endothelial progenitor cells and cardiovascular disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Number of circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Specific role of impaired glucose metabolism and diabetes mellitus in endothelial progenitor cell characteristics and function

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Prognostic significance of circulating and endothelial progenitor cell markers in type 2 diabetic foot.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Potential benefits of cell therapy in coronary heart disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Impaired endothelial progenitor cell mobilization and dysfunctional bone marrow stroma in diabetes mellitus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Endothelial progenitor cells as therapeutic agents in the microcirculation: an update

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Effects of insulin resistance on endothelial progenitor cells and vascular repair

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Isolation of putative progenitor endothelial cells for angiogenesis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Type 2 diabetes mellitus impairs endothelial progenitor cells functions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Endothelial progenitor cells and human diseases.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Comparison between total endothelial progenitor cell isolation versus enriched Cd133+ culture.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4961113

Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension

4 December 2018

1 reference

12 December 2020

Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease

1 reference

12 December 2020

Glycoxydation promotes vascular damage Via MAPK-ERK/JNK pathways

1 reference

12 December 2020

Diabetes alters subsets of endothelial progenitor cells that reside in blood, bone marrow, and spleen

1 reference

12 December 2020

C-peptide concentration, mortality and vascular complications in people with Type 2 diabetes. The Skaraborg Diabetes Register

1 reference

12 December 2020

In vitro vessel-forming capacity of endothelial progenitor cells in high glucose conditions

1 reference

12 December 2020

CD34 + and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure

1 reference

12 December 2020

Circulating endothelial progenitor cells predict coronary artery disease severity

1 reference

12 December 2020

10.15283/IJSC.2016.9.1.137

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference